Biggest News Aggregation in the World
📰 Support Potential Approval News

Support Potential Approval News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Support Potential Approval. Real-time updates on events, politics, business and more.

Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2023 and Reiterates Key Anticipated Near-Term Milestones

14.08.2023 - Prescription Drug User Fee Act (PDUFA) goal date of August 29, 2023 for ONS-5010, an investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD) ISELIN, N.J., Aug. 14, 2023 (GLOBE ...
United States United Kingdom Harriet Ullman Jenene Thomas Committee For Medicinal Products Human Use Alliance Healthcare

Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2023 and Provides Corporate Update

15.05.2023 - Upcoming Prescription Drug User Fee Act (PDUFA) goal date of August 29, 2023 for ONS-5010, an investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD)Pre-launch commercial activities ...
United States United Kingdom Jenene Thomas Harriet Ullman Outlook Therapeutics Inc Lavoie Health Science

Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc.

-- First-Quarter 2021 Net Sales of $342.4 Million; First-Quarter 2021 GAAP Net Loss of $123.4 Million; Adjusted EBITDA of $45.8 Million -- -- First-Quarter 2021 Orphan Segment Net Sales Increased
United States Viela Bio Ruth Venning Geoff Curtis Tim Walbert Tina Ventura

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science